Both leverage ai models to enhance/ optimize drug discovery. They both have strong backers and partnerships. Schrödinger is slightly more established with a few drugs already on the market in collaboration with big pharma. For me at their current PS ratio and risk, I prefer Schrödinger. What are your thoughts?
Leave a Reply